CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: EDIT), a ...
HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company pioneering CRISPR-based programmable genome medicines, today announced the appointment of Dr. TJ Cradick as Chief ...
This funding, provided through the NIH’s Somatic Cell Genome Editing Program, will support gene-editing research aimed at ...
As Shift Bioscience raises $16 million in seed funding, delve into the field of cellular reprogramming to tackle age-related ...
An exploration of AI's transformative potential according to Dario Amodei, highlighting its risks to democracy and the ...
Gene-editing therapies—techniques that modify DNA to treat or prevent disease—have the potential to transform the field of ...
Scientists play a critical role in developing new medicines, ensuring treatments are both safe and effective. From ...